UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Understanding the SARS-CoV-2 Virus Neutralizing Antibody Response: Lessons to Be Learned from HIV and Respiratory Syncytial Virus

Viruses, 2023-02, Vol.15 (2), p.504

2023

Volltextzugriff (PDF)

Cloned Defective Interfering Influenza RNA and a Possible Pan-Specific Treatment of Respiratory Virus Diseases

Viruses, 2015-07, Vol.7 (7), p.3768-3788

2015

Volltextzugriff (PDF)

COVID-19 Infection, Vaccines, and Immunity—The Antibody Response Requires Detailed Analysis

Microbiology research, 2021-09, Vol.12 (3), p.626-629

Dimmock, Nigel J.

2021

Volltextzugriff (PDF)

Live Attenuated Influenza Vaccine contains Substantial and Unexpected Amounts of Defective Viral Genomic RNA

Viruses, 2017-09, Vol.9 (10), p.269

2017

Volltextzugriff (PDF)

Low dose influenza virus challenge in the ferret leads to increased virus shedding and greater sensitivity to oseltamivir

PloS one, 2014-04, Vol.9 (4), p.e94090-e94090

2014

Volltextzugriff (PDF)

A novel broad-spectrum treatment for respiratory virus infections: Influenza-based defective interfering virus provides protection against pneumovirus infection in vivo

Vaccine, 2011-03, Vol.29 (15), p.2777-2784

2011

Volltextzugriff (PDF)

Defective interfering influenza virus RNAs: time to reevaluate their clinical potential as broad-spectrum antivirals?

Journal of virology, 2014-05, Vol.88 (10), p.5217-5227

2014

Volltextzugriff (PDF)

Defective interfering influenza A virus protects in vivo against disease caused by a heterologous influenza B virus

Journal of general virology, 2011-09, Vol.92 (Pt 9), p.2122-2132

2011

Volltextzugriff (PDF)

Cloned defective interfering influenza virus protects ferrets from pandemic 2009 influenza A virus and allows protective immunity to be established

PloS one, 2012-12, Vol.7 (12), p.e49394-e49394

2012

Volltextzugriff (PDF)

Influenza Virus Protecting RNA: an Effective Prophylactic and Therapeutic Antiviral

Journal of Virology, 2008-09, Vol.82 (17), p.8570-8578

2008

Volltextzugriff (PDF)

Unexpected complexity in the interference activity of a cloned influenza defective interfering RNA

Virology journal, 2017-07, Vol.14 (1), p.138-138, Article 138

2017

Volltextzugriff (PDF)

A Defective Interfering Influenza RNA Inhibits Infectious Influenza Virus Replication in Human Respiratory Tract Cells: A Potential New Human Antiviral

Viruses, 2016-08, Vol.8 (8), p.237

2016

Volltextzugriff (PDF)

Defective interfering influenza virus confers only short-lived protection against influenza virus disease: Evidence for a role for adaptive immunity in DI virus-mediated protection in vivo

Vaccine, 2011-09, Vol.29 (38), p.6584-6591

2011

Volltextzugriff (PDF)

Comparison of the protection of ferrets against pandemic 2009 influenza A virus (H1N1) by 244 DI influenza virus and oseltamivir

Antiviral research, 2012-12, Vol.96 (3), p.376-385

2012

Volltextzugriff (PDF)

Can defective interfering RNAs affect the live attenuated influenza vaccine?

The Lancet infectious diseases, 2017-12, Vol.17 (12), p.1234-1235

2017

Volltextzugriff (PDF)

Defective interfering virus protects elderly mice from influenza

Virology journal, 2011-05, Vol.8 (1), p.212-212, Article 212

2011

Volltextzugriff (PDF)

The receptor preference of influenza viruses

Influenza and other respiratory viruses, 2010-05, Vol.4 (3), p.147-153

2010

Volltextzugriff (PDF)

Analysis of a 17-amino acid residue, virus-neutralizing microantibody

Journal of general virology, 2005-06, Vol.86 (6), p.1791-1800

2005

Volltextzugriff (PDF)

Valency of Antibody Binding to Enveloped Virus Particles as Determined by Surface Plasmon Resonance

Journal of Virology, 2003-01, Vol.77 (2), p.1649-1652

2003

Volltextzugriff (PDF)

Summary of Antibody Workshop: The Role of Humoral Immunity in the Treatment and Prevention of Emerging and Extant Infectious Diseases

The Journal of infectious diseases, 1997-09, Vol.176 (3), p.549-559

1997

Volltextzugriff (PDF)

Binding of an influenza A virus to a neomembrane measured by surface plasmon resonance

Bioorganic & medicinal chemistry, 2004-05, Vol.12 (10), p.2773-2780

2004

Volltextzugriff (PDF)

The C-terminal tail of the gp41 transmembrane envelope glycoprotein of HIV-1 clades A, B, C, and D may exist in two conformations: an analysis of sequence, structure, and function

Virology (New York, N.Y.), 2005-07, Vol.337 (2), p.284-296

2005

Volltextzugriff (PDF)

In vivo antiviral activity: defective interfering virus protects better against virulent Influenza A virus than avirulent virus

Journal of general virology, 2006-05, Vol.87 (5), p.1259-1265

2006

Volltextzugriff (PDF)

The complex antigenicity of a small external region of the C-terminal tail of the HIV-1 gp41 envelope protein: a lesson in epitope analysis

Reviews in medical virology, 2005-11, Vol.15 (6), p.365-381

Dimmock, Nigel J.

2005

Volltextzugriff (PDF)

Interfering vaccine: a novel antiviral that converts a potentially virulent infection into one that is subclinical and immunizing

Vaccine, 2004-08, Vol.22 (23), p.3018-3025

2004

Volltextzugriff (PDF)

1 – 25 von 115

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(79)
Mit Volltextzugriff
(79)

Publikationsform

Sprache

Englisch
(115)

Erscheinungsjahr

n.n

Thema

Science & Technology
(66)
Life Sciences & Biomedicine
(64)
Virology
(57)
Animals
(48)
Humans
(29)
Biological And Medical Sciences
(25)
Mice
(25)
Microbiology
(25)
Cell Line
(23)
Fundamental And Applied Biological Sciences. Psychology
(23)
Coping With Illness
(21)
Human Immunodeficiency Virus 1
(17)
Hiv-1 - Immunology
(16)
Neutralization Tests
(16)
Virus Replication
(16)
Aids/hiv
(15)
Biotechnology & Applied Microbiology
(15)
Viruses
(14)
Hiv Antibodies - Immunology
(13)
Influenza A Virus
(13)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Understanding the SARS-CoV-2 Virus Neutralizing Antibody Response: Lessons to Be Learned from HIV and Respiratory Syncytial Virus

Cloned Defective Interfering Influenza RNA and a Possible Pan-Specific Treatment of Respiratory Virus Diseases

COVID-19 Infection, Vaccines, and Immunity—The Antibody Response Requires Detailed Analysis

Live Attenuated Influenza Vaccine contains Substantial and Unexpected Amounts of Defective Viral Genomic RNA

Low dose influenza virus challenge in the ferret leads to increased virus shedding and greater sensitivity to oseltamivir

A novel broad-spectrum treatment for respiratory virus infections: Influenza-based defective interfering virus provides protection against pneumovirus infection in vivo

Defective interfering influenza virus RNAs: time to reevaluate their clinical potential as broad-spectrum antivirals?

Defective interfering influenza A virus protects in vivo against disease caused by a heterologous influenza B virus

Cloned defective interfering influenza virus protects ferrets from pandemic 2009 influenza A virus and allows protective immunity to be established

Influenza Virus Protecting RNA: an Effective Prophylactic and Therapeutic Antiviral

Unexpected complexity in the interference activity of a cloned influenza defective interfering RNA

A Defective Interfering Influenza RNA Inhibits Infectious Influenza Virus Replication in Human Respiratory Tract Cells: A Potential New Human Antiviral

Defective interfering influenza virus confers only short-lived protection against influenza virus disease: Evidence for a role for adaptive immunity in DI virus-mediated protection in vivo

Comparison of the protection of ferrets against pandemic 2009 influenza A virus (H1N1) by 244 DI influenza virus and oseltamivir

Can defective interfering RNAs affect the live attenuated influenza vaccine?

Defective interfering virus protects elderly mice from influenza

The receptor preference of influenza viruses

Analysis of a 17-amino acid residue, virus-neutralizing microantibody

Valency of Antibody Binding to Enveloped Virus Particles as Determined by Surface Plasmon Resonance

Summary of Antibody Workshop: The Role of Humoral Immunity in the Treatment and Prevention of Emerging and Extant Infectious Diseases

Binding of an influenza A virus to a neomembrane measured by surface plasmon resonance

The C-terminal tail of the gp41 transmembrane envelope glycoprotein of HIV-1 clades A, B, C, and D may exist in two conformations: an analysis of sequence, structure, and function

In vivo antiviral activity: defective interfering virus protects better against virulent Influenza A virus than avirulent virus

The complex antigenicity of a small external region of the C-terminal tail of the HIV-1 gp41 envelope protein: a lesson in epitope analysis

Interfering vaccine: a novel antiviral that converts a potentially virulent infection into one that is subclinical and immunizing

Suchergebnisse filtern